BrainIAC, a new foundation model from Mass General Brigham, outperforms traditional AI approaches in analyzing brain MRI for tasks like brain age estimation and cancer prognosis.
Key Details
- 1BrainIAC was pretrained on nearly 49,000 brain MRI scans using self-supervised learning.
- 2Validated across seven diverse clinical MRI tasks, including brain age, dementia risk, tumor mutation detection, and survival prediction.
- 3Outperformed three conventional, task-specific AI models, especially in scenarios with limited labeled data.
- 4Demonstrated strong generalizability across healthy and diseased cases as well as different MRI types.
- 5Study published in Nature Neuroscience, developed by Mass General Brigham, and funded by NIH/NCI among others.
Why It Matters
This work introduces a flexible, generalizable AI tool that could streamline the adoption of imaging AI in clinical practice, particularly where annotated data is limited. BrainIAC's ability to perform well across a range of complex imaging tasks may help accelerate personalized medicine and clinical decision making in neuroradiology.
Source
EurekAlert
Related News
•EurekAlert
AI Pathology Tool SÉMIL Improves Stage II Bowel Cancer Risk Assessment
A La Trobe University-developed AI tool accurately predicts relapse risk in stage II bowel cancer using digital pathology images and descriptions.
•EurekAlert
AI Tool Predicts Which Rectal Cancer Patients Benefit from Intensive Therapy
UCL researchers developed an AI that analyzes biopsy slides to identify rectal cancer patients who benefit from adding irinotecan to standard chemoradiotherapy.
•EurekAlert
AI-Guided Handheld Cardiac Ultrasound Reduces Referrals and Costs in Spain
AI-guided handheld cardiac ultrasound enables primary care physicians to detect heart failure, reducing specialist referrals and saving costs.